Global mRNA Sequencing Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global mRNA Sequencing market size will reach US$ 11980 million by 2031.
mRNA sequencing (mRNA-Seq) has rapidly become the method of choice for analyzing the transcriptomes of disease states, of biological processes, and across a wide range of study designs. In addition to being a highly sensitive and accurate means of quantifying gene expression, mRNA-Seq can identify both known and novel transcript isoforms, gene fusions, and other features as well as allele-specific expression. mRNA-Seq delivers a complete view of the coding transcriptome that is not restricted by the filter of prior knowledge.
A significant driver in the mRNA Sequencing market is the rapid advancements in genomics research and the growing interest in studying gene expression at the mRNA level. mRNA sequencing, also known as RNA-Seq, provides a powerful tool for understanding the transcriptome and identifying differentially expressed genes across various biological conditions. However, a notable challenge in this market is the need for data analysis and standardization. Ensuring that researchers can efficiently analyze and interpret the vast amount of mRNA sequencing data generated while addressing potential variations in protocols and data processing poses a significant challenge. Bioinformatics solutions, data analysis pipelines, and data-sharing standards must be continuously developed to facilitate data interpretation and integration, promoting the widespread adoption of mRNA sequencing in genomics research and clinical applications.
LPI (LP Information)' newest research report, the “mRNA Sequencing Industry Forecast” looks at past sales and reviews total world mRNA Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected mRNA Sequencing sales for 2025 through 2031. With mRNA Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Sequencing industry.
This Insight Report provides a comprehensive analysis of the global mRNA Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on mRNA Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Sequencing.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Sequencing market by product type, application, key players and key regions and countries.
Segmentation by Type:
PCR
Microarray
Sequencing
Segmentation by Application:
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Please note: The report will take approximately 2 business days to prepare and deliver.
mRNA sequencing (mRNA-Seq) has rapidly become the method of choice for analyzing the transcriptomes of disease states, of biological processes, and across a wide range of study designs. In addition to being a highly sensitive and accurate means of quantifying gene expression, mRNA-Seq can identify both known and novel transcript isoforms, gene fusions, and other features as well as allele-specific expression. mRNA-Seq delivers a complete view of the coding transcriptome that is not restricted by the filter of prior knowledge.
A significant driver in the mRNA Sequencing market is the rapid advancements in genomics research and the growing interest in studying gene expression at the mRNA level. mRNA sequencing, also known as RNA-Seq, provides a powerful tool for understanding the transcriptome and identifying differentially expressed genes across various biological conditions. However, a notable challenge in this market is the need for data analysis and standardization. Ensuring that researchers can efficiently analyze and interpret the vast amount of mRNA sequencing data generated while addressing potential variations in protocols and data processing poses a significant challenge. Bioinformatics solutions, data analysis pipelines, and data-sharing standards must be continuously developed to facilitate data interpretation and integration, promoting the widespread adoption of mRNA sequencing in genomics research and clinical applications.
LPI (LP Information)' newest research report, the “mRNA Sequencing Industry Forecast” looks at past sales and reviews total world mRNA Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected mRNA Sequencing sales for 2025 through 2031. With mRNA Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Sequencing industry.
This Insight Report provides a comprehensive analysis of the global mRNA Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on mRNA Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Sequencing.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Sequencing market by product type, application, key players and key regions and countries.
Segmentation by Type:
PCR
Microarray
Sequencing
Segmentation by Application:
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
88 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 mRNA Sequencing Market Size by Player
- 4 mRNA Sequencing by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global mRNA Sequencing Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
